[Immunosuppressive therapy of systemic lupus erythematosus].
D001379:Azathioprine / Q000627:therapeutic use; D003165:Complement System Proteins / Q000032:analysis; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D003165:Complement System Proteins; D001379:Azathioprine; D011241:Prednisone; D008727:Methotrexate
Die immunsuppressive Therapie des systemischen Lupus erythematodes (SLE.